Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Docetaxel injection and preparation method thereof

A docetaxel, injection technology, applied in pharmaceutical formulations, oil/fat/wax inactive ingredients, drug combinations, etc., can solve problems such as interference with P-glycoprotein expression, temperature sensitivity, patient death, etc., and achieve stability Good performance, stable active ingredient content, good safety effect

Inactive Publication Date: 2016-03-16
HAINAN GENERAL & KANGLI PHARMA
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Docetaxel injection is sensitive to temperature. The storage temperature of domestic docetaxel injection is 2-8°C, and the storage temperature of imported docetaxel injection is 2-25°C. The marketed docetaxel injection cannot Store in an environment above 25°C for long-term storage; in addition, the docetaxel injections that have been marketed all use the surfactant Tween 80, which has a hemolytic effect and is likely to cause serious adverse reactions of acute intravascular hemolysis, even It can lead to the death of patients. Tween 80 can interfere with the expression of P-glycoprotein and interact with certain drugs. Therefore, glucocorticoids, such as dexamethasone, should be used before medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Docetaxel injection and preparation method thereof
  • Docetaxel injection and preparation method thereof
  • Docetaxel injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Preparation of docetaxel injection: mix 10 g of absolute ethanol and 8 g of glycerin evenly, add 0.2 g of anhydrous citric acid and 0.2 g of tartaric acid to completely dissolve, and stir well; add 1 g of docetaxel, and stir until completely dissolved; add 15g polyoxyethylene ether (35) castor oil and 11g polyoxyethylene ether (40) castor oil, stir and mix well; add 30g polyethylene glycol 300 and 25g polyethylene glycol 400, stir and mix well, you can get Dorsey Taxal injection.

Embodiment 2

[0022] Preparation of docetaxel injection: mix 10g of absolute ethanol and 8g of 1,2-propanediol evenly, add 0.2g of anhydrous citric acid and 0.2g of fumaric acid to dissolve completely, stir well; add 1.5g of docetaxel , stir until completely dissolved; add 15g polyoxyethylene ether (35) castor oil and 11g polyoxyethylene castor oil EL, stir and mix evenly; add 30g polyethylene glycol 300 and 25g polyethylene glycol 400, stir and mix evenly, namely Docetaxel injection is available.

Embodiment 3

[0024] Preparation of docetaxel injection: mix 10 g of absolute ethanol and 8 g of 1,2-propanediol evenly, add 0.2 g of anhydrous citric acid and 0.2 g of maleic acid to dissolve completely, and stir well; add 1.5 g of docetaxel , stir until completely dissolved; add 15g polyoxyethylene ether (35) castor oil and 11g polyoxyethylene castor oil EL, stir and mix evenly; add 40g polyethylene glycol 300 and 15g polyethylene glycol 400, stir and mix evenly, namely Docetaxel injection is available.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses docetaxel injection. The docetaxel injection is prepared from the following components in parts by weight: 1-2 parts of docetaxel, 18-25 parts of a solvent, 20-30 parts of a surfactant, 0.3-0.6 part of a stabilizer, and 40-60 parts of a solubilizer, wherein the solvent is one or more of absolute ethyl alcohol, glycerol and propylene glycol, the surfactant is polyoxyethylenated castor oil, the stabilizer is one or more of citric acid, tartaric acid, fumaric acid and maleic acid, and the solubilizer is polyethylene glycol 300 and / or polyethylene glycol 400. The docetaxel injection provided by the invention is free of hemolysis, good in safety, good in stability, stable in content of active ingredients, and low in contents of related substances and impurities, and can be stored under the condition with the temperature being 20-40 DEG C.

Description

technical field [0001] The invention relates to docetaxel injection and a preparation method thereof, belonging to the field of pharmaceutical preparations. Background technique [0002] Docetaxel (Docetaxel or Docetaxel) is a taxane anticancer drug developed by the French company Rhone-Planck Le'an and has been widely marketed. It is a white or nearly white powder with a molecular formula of C 43 h 53 NO 4 , with a relative molecular mass of 861.9, is a product obtained by semi-synthesis of the extract from the needles of Yew berry. Since docetaxel replaces the benzoic acid group in paclitaxel with t-butoxycarbonyl, its water solubility is slightly greater than that of paclitaxel (the solubility of paclitaxel in water is less than 0.004g / L). Its mechanism of action is to promote tubulin polymerization and inhibit microtubule depolymerization, "freeze" the synthesis of intracellular skeleton, a component of microtubules, resulting in the formation of stable non-functiona...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/337A61K9/08A61K47/44A61P35/00
Inventor 熊景辉刘俊管涛柳旭曹俊沈立姿林方育
Owner HAINAN GENERAL & KANGLI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com